Atlas Trials

A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease

Clinical trial NCT01396213 · COMPLETED

Trial details

NCT number
NCT01396213
Sponsor
9 Meters Biopharma, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Celiac Disease
Start date
2011-11-07
Primary completion
2013-08-20
Enrollment
342

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.